Show Summary Details
Page of

Commentary: Future Directions in the Treatment of Autism Spectrum Disorders 

Commentary: Future Directions in the Treatment of Autism Spectrum Disorders

Chapter:
Commentary: Future Directions in the Treatment of Autism Spectrum Disorders
Author(s):

Evdokia Anagnostou

, Mark F. Bear

, and Geraldine Dawson

DOI:
10.1093/med/9780195371826.003.0081
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 18 August 2017

This commentary considers current challenges, gaps, and future directions of with autism spectrum disorders (ASD) treatment research, including research on neuropsychopharmacological and behavioral/psychosocial interventions for ASD. Emerging data from basic science (neuropathology, genetics/genomics/proteomics, animal models) have made it possible to start identifying neurochemical systems involved in the pathophysiology of autism that can be specifically targeted with neuropsychopharmacological interventions. It is anticipated that, ultimately, pharmacological agents targeting systems involved in the pathophysiology of ASD will be used to facilitate existing behavioral interventions.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.